CIHR Operating Grant: Addressing the Wider Health Impacts of COVID-19
Launched in early September, this funding opportunity seeks research proposals to address the gaps in knowledge about the wider impacts of the COVID-19 pandemic and response on the health and health care of people in Canada. Suspension/interruption of cancer screening is one of the research areas of focus.
The maximum amount per grant that can be requested for clinical trial research is $1,000,000 over 2 years; for other types of research, the maximum amount per grant is $500,000 over 2 years. Registration deadline is October 18, 2021. For more information, see https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=3548&language=E.
CanPath Webinar: How Population Cohorts Can Support COVID-19 Research
CanPath, in partnership with the University of Toronto’s Dalla Lana School of Public Health, will provide a webinar on Wednesday June 24th (Noon to 1:00 pm EDT) on how large population cohorts can respond in a pandemic and support rapid national research efforts. The webinar will featur... Read More »
CanPath, in partnership with the University of Toronto’s Dalla Lana School of Public Health, will provide a webinar on Wednesday June 24th (Noon to 1:00 pm EDT) on how large population cohorts can respond in a pandemic and support rapid national research efforts. The webinar will featur... Read More »
$473M Invested in Cancer Research in 2016
CCRA released its latest reports on the investment in cancer research. In addition to the overview report, there are brief reports on the research investments made in childhood and adolescent cancers, cancer risk and prevention, cancer survivorship, palliative and end-of-life cancer care and translational research. Reports are av... Read More »
CCRA released its latest reports on the investment in cancer research. In addition to the overview report, there are brief reports on the research investments made in childhood and adolescent cancers, cancer risk and prevention, cancer survivorship, palliative and end-of-life cancer care and translational research. Reports are av... Read More »